annual CAPEX:
$182.00K-$826.00K(-81.94%)Summary
- As of today (August 20, 2025), ABUS annual capital expenditures is $182.00 thousand, with the most recent change of -$826.00 thousand (-81.94%) on December 31, 2024.
- During the last 3 years, ABUS annual CAPEX has fallen by -$627.00 thousand (-77.50%).
- ABUS annual CAPEX is now -97.54% below its all-time high of $7.38 million, reached on December 31, 1998.
Performance
ABUS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
quarterly CAPEX:
$0.00$0.00(0.00%)Summary
- As of today (August 20, 2025), ABUS quarterly capital expenditures is $0.00, unchanged on June 30, 2025.
- Over the past year, ABUS quarterly CAPEX has dropped by -$300.00 (-100.00%).
- ABUS quarterly CAPEX is now -100.00% below its all-time high of $3.42 million, reached on March 31, 2017.
Performance
ABUS quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
TTM CAPEX:
$83.00K-$300.00(-0.36%)Summary
- As of today (August 20, 2025), ABUS TTM capital expenditures is $83.00 thousand, with the most recent change of -$300.00 (-0.36%) on June 30, 2025.
- Over the past year, ABUS TTM CAPEX has dropped by -$31.70 thousand (-27.64%).
- ABUS TTM CAPEX is now -99.16% below its all-time high of $9.94 million, reached on September 30, 2017.
Performance
ABUS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
ABUS CAPEX Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -81.9% | -100.0% | -27.6% |
3 y3 years | -77.5% | -100.0% | -76.2% |
5 y5 years | -69.1% | -100.0% | -78.5% |
ABUS CAPEX Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | -81.9% | at low | -100.0% | +100.0% | -93.0% | +1.0% |
5 y | 5-year | -81.9% | at low | -100.0% | +100.0% | -93.0% | +1.0% |
alltime | all time | -97.5% | +1129.7% | -100.0% | +100.0% | -99.2% | +2577.4% |
ABUS CAPEX History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Jun 2025 | - | $0.00(0.0%) | $83.00K(-0.4%) |
Mar 2025 | - | $0.00(-100.0%) | $83.30K(-53.3%) |
Dec 2024 | $182.00K(-81.9%) | $82.70K(>+9900.0%) | $178.30K(+116.9%) |
Sep 2024 | - | $300.00(0.0%) | $82.20K(-28.3%) |
Jun 2024 | - | $300.00(-99.7%) | $114.70K(-88.3%) |
Mar 2024 | - | $95.00K(-809.0%) | $976.80K(-2.2%) |
Dec 2023 | $1.01M(+96.9%) | -$13.40K(-140.9%) | $998.80K(-11.8%) |
Sep 2023 | - | $32.80K(-96.2%) | $1.13M(-4.4%) |
Jun 2023 | - | $862.40K(+637.1%) | $1.18M(+122.3%) |
Mar 2023 | - | $117.00K(-2.3%) | $533.00K(+8.6%) |
Dec 2022 | $512.00K(-36.7%) | $119.70K(+40.0%) | $491.00K(+14.7%) |
Sep 2022 | - | $85.50K(-59.4%) | $428.20K(+23.0%) |
Jun 2022 | - | $210.80K(+181.1%) | $348.00K(-55.4%) |
Mar 2022 | - | $75.00K(+31.8%) | $780.60K(-3.0%) |
Dec 2021 | $809.00K(+253.3%) | $56.90K(+973.6%) | $804.60K(-11.1%) |
Sep 2021 | - | $5300.00(-99.2%) | $905.40K(-0.8%) |
Jun 2021 | - | $643.40K(+549.9%) | $913.10K(+172.8%) |
Mar 2021 | - | $99.00K(-37.2%) | $334.70K(+42.0%) |
Dec 2020 | $229.00K(-61.1%) | $157.70K(+1113.1%) | $235.70K(+68.2%) |
Sep 2020 | - | $13.00K(-80.0%) | $140.10K(-63.8%) |
Jun 2020 | - | $65.00K(>+9900.0%) | $386.90K(-31.0%) |
Mar 2020 | - | $0.00(-100.0%) | $561.00K(-5.2%) |
Dec 2019 | $589.00K(-48.2%) | $62.10K(-76.1%) | $592.00K(-21.0%) |
Sep 2019 | - | $259.80K(+8.7%) | $749.80K(+4.0%) |
Jun 2019 | - | $239.10K(+671.3%) | $720.70K(-19.9%) |
Mar 2019 | - | $31.00K(-85.9%) | $899.80K(-19.4%) |
Dec 2018 | $1.14M(-84.3%) | $219.90K(-4.7%) | $1.12M(+21.3%) |
Sep 2018 | - | $230.70K(-44.8%) | $920.60K(-42.3%) |
Jun 2018 | - | $418.20K(+68.6%) | $1.60M(-62.4%) |
Mar 2018 | - | $248.00K(+946.4%) | $4.24M(-42.8%) |
Dec 2017 | $7.26M(+81.8%) | $23.70K(-97.4%) | $7.42M(-25.4%) |
Sep 2017 | - | $905.50K(-70.5%) | $9.94M(+8.2%) |
Jun 2017 | - | $3.06M(-10.5%) | $9.19M(+29.1%) |
Mar 2017 | - | $3.42M(+34.4%) | $7.11M(+79.3%) |
Dec 2016 | $4.00M(+74.7%) | $2.55M(+1583.2%) | $3.97M(+55.6%) |
Sep 2016 | - | $151.30K(-84.8%) | $2.55M(-13.1%) |
Jun 2016 | - | $993.80K(+260.1%) | $2.93M(+26.2%) |
Mar 2016 | - | $276.00K(-75.5%) | $2.33M(+6.2%) |
Dec 2015 | $2.29M(+116.6%) | $1.13M(+110.3%) | $2.19M(+61.7%) |
Sep 2015 | - | $536.40K(+39.2%) | $1.35M(+39.8%) |
Jun 2015 | - | $385.40K(+173.3%) | $969.10K(+16.3%) |
Mar 2015 | - | $141.00K(-51.7%) | $833.00K(-18.9%) |
Dec 2014 | $1.06M(+45.6%) | $292.20K(+94.2%) | $1.03M(+11.6%) |
Sep 2014 | - | $150.50K(-39.6%) | $920.50K(+4.3%) |
Jun 2014 | - | $249.30K(-25.6%) | $882.30K(+4.8%) |
Mar 2014 | - | $335.00K(+80.4%) | $842.20K(+18.3%) |
Dec 2013 | $725.10K(+4799.3%) | $185.70K(+65.4%) | $712.00K(+34.7%) |
Sep 2013 | - | $112.30K(-46.3%) | $528.40K(+26.9%) |
Jun 2013 | - | $209.20K(+2.1%) | $416.30K(+90.2%) |
Mar 2013 | - | $204.80K(+9652.4%) | $218.90K(+1369.1%) |
Dec 2012 | $14.80K(-75.5%) | $2100.00(+950.0%) | $14.90K(+9.6%) |
Sep 2012 | - | $200.00(-98.3%) | $13.60K(+7.1%) |
Jun 2012 | - | $11.80K(+1375.0%) | $12.70K(+309.7%) |
Mar 2012 | - | $800.00(0.0%) | $3100.00(-94.7%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Dec 2011 | $60.30K(-92.5%) | $800.00(-214.3%) | $58.40K(-56.7%) |
Sep 2011 | - | -$700.00(-131.8%) | $134.80K(-33.1%) |
Jun 2011 | - | $2200.00(-96.1%) | $201.60K(-44.4%) |
Mar 2011 | - | $56.10K(-27.3%) | $362.70K(-56.7%) |
Dec 2010 | $806.70K(-41.7%) | $77.20K(+16.8%) | $837.00K(-32.5%) |
Sep 2010 | - | $66.10K(-59.5%) | $1.24M(-13.2%) |
Jun 2010 | - | $163.30K(-69.2%) | $1.43M(+3.3%) |
Mar 2010 | - | $530.40K(+10.3%) | $1.38M(-7.5%) |
Dec 2009 | $1.38M(+25.6%) | $480.80K(+88.5%) | $1.50M(+22.1%) |
Sep 2009 | - | $255.00K(+116.1%) | $1.23M(+1.0%) |
Jun 2009 | - | $118.00K(-81.6%) | $1.21M(-13.5%) |
Mar 2009 | - | $642.10K(+205.3%) | $1.40M(+44.5%) |
Dec 2008 | $1.10M(-12.4%) | $210.30K(-13.5%) | $971.00K(-9.5%) |
Sep 2008 | - | $243.10K(-20.9%) | $1.07M(+1.9%) |
Jun 2008 | - | $307.50K(+46.4%) | $1.05M(-16.2%) |
Mar 2008 | - | $210.10K(-32.6%) | $1.25M(-8.9%) |
Dec 2007 | $1.26M(+1190.7%) | $311.80K(+40.1%) | $1.38M(+27.5%) |
Sep 2007 | - | $222.60K(-56.4%) | $1.08M(+24.0%) |
Jun 2007 | - | $510.40K(+53.5%) | $871.20K(+110.9%) |
Mar 2007 | - | $332.40K(+2145.9%) | $413.00K(+325.8%) |
Dec 2006 | $97.50K(+126.2%) | - | - |
Dec 2006 | - | $14.80K(+8.8%) | $97.00K(+16.6%) |
Sep 2006 | - | $13.60K(-73.9%) | $83.20K(+17.0%) |
Jun 2006 | - | $52.20K(+218.3%) | $71.10K(+181.0%) |
Mar 2006 | - | $16.40K(+1540.0%) | $25.30K(-43.3%) |
Dec 2005 | $43.10K(-95.4%) | - | - |
Dec 2005 | - | $1000.00(-33.3%) | $44.60K(-71.3%) |
Sep 2005 | - | $1500.00(-76.6%) | $155.20K(-50.4%) |
Jun 2005 | - | $6400.00(-82.1%) | $312.60K(-60.6%) |
Mar 2005 | - | $35.70K(-68.0%) | $794.20K(-20.5%) |
Dec 2004 | $937.10K(+28.5%) | - | - |
Dec 2004 | - | $111.60K(-29.8%) | $999.10K(-25.7%) |
Sep 2004 | - | $158.90K(-67.4%) | $1.34M(+8.3%) |
Jun 2004 | - | $488.00K(+102.8%) | $1.24M(+26.0%) |
Mar 2004 | - | $240.60K(-47.4%) | $986.30K(+27.1%) |
Dec 2003 | $729.50K(-62.7%) | - | - |
Dec 2003 | - | $457.30K(+710.8%) | $776.20K(+18.3%) |
Sep 2003 | - | $56.40K(-75.7%) | $656.40K(-43.3%) |
Jun 2003 | - | $232.00K(+660.7%) | $1.16M(-23.2%) |
Mar 2003 | - | $30.50K(-91.0%) | $1.51M(-23.0%) |
Dec 2002 | $1.96M(+110.8%) | - | - |
Dec 2002 | - | $337.50K(-39.5%) | $1.96M(+14.4%) |
Sep 2002 | - | $557.90K(-4.0%) | $1.71M(+22.7%) |
Jun 2002 | - | $581.20K(+21.2%) | $1.39M(+23.2%) |
Mar 2002 | - | $479.70K(+426.0%) | $1.13M(+24.4%) |
Dec 2001 | $927.90K(+352.0%) | - | - |
Dec 2001 | - | $91.20K(-62.2%) | $909.10K(+11.2%) |
Sep 2001 | - | $241.50K(-24.2%) | $817.90K(+41.9%) |
Jun 2001 | - | $318.80K(+23.8%) | $576.40K(+123.8%) |
Mar 2001 | - | $257.60K | $257.60K |
Dec 2000 | $205.30K(-30.0%) | - | - |
Dec 1999 | $293.10K(-96.0%) | - | - |
Dec 1998 | $7.38M(+190.3%) | - | - |
Dec 1997 | $2.54M | - | - |
FAQ
- What is Arbutus Biopharma Corporation annual capital expenditures?
- What is the all time high annual CAPEX for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation annual CAPEX year-on-year change?
- What is Arbutus Biopharma Corporation quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation quarterly CAPEX year-on-year change?
- What is Arbutus Biopharma Corporation TTM capital expenditures?
- What is the all time high TTM CAPEX for Arbutus Biopharma Corporation?
- What is Arbutus Biopharma Corporation TTM CAPEX year-on-year change?
What is Arbutus Biopharma Corporation annual capital expenditures?
The current annual CAPEX of ABUS is $182.00K
What is the all time high annual CAPEX for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high annual capital expenditures is $7.38M
What is Arbutus Biopharma Corporation annual CAPEX year-on-year change?
Over the past year, ABUS annual capital expenditures has changed by -$826.00K (-81.94%)
What is Arbutus Biopharma Corporation quarterly capital expenditures?
The current quarterly CAPEX of ABUS is $0.00
What is the all time high quarterly CAPEX for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high quarterly capital expenditures is $3.42M
What is Arbutus Biopharma Corporation quarterly CAPEX year-on-year change?
Over the past year, ABUS quarterly capital expenditures has changed by -$300.00 (-100.00%)
What is Arbutus Biopharma Corporation TTM capital expenditures?
The current TTM CAPEX of ABUS is $83.00K
What is the all time high TTM CAPEX for Arbutus Biopharma Corporation?
Arbutus Biopharma Corporation all-time high TTM capital expenditures is $9.94M
What is Arbutus Biopharma Corporation TTM CAPEX year-on-year change?
Over the past year, ABUS TTM capital expenditures has changed by -$31.70K (-27.64%)